PLAU and CTSK have been shown to play a role in various tumors, with PLAU being considered as a potential biomarker in head and neck squamous cell carcinoma [10], promoting the EMT process [11], and tumor development in gastric cancer by cooperating with FOXM1 [12]. The gene discussed is PLAU; the disease is gastric cancer.